Incyte

United Therapeutics

Gilead Sciences

Natera

Neurocrine Biosciences

Alnylam Pharmaceuticals

Vertex Pharmaceuticals

Insmed

Sarepta Therapeutics

Viking Therapeutics

SPDR S&P Biotech ETF

XBI tracks an equal-weighted index of US biotechnology stocks.

ARK Genomic Revolution Multi-Sector ETF

VanEck Vectors Biotech ETF

First Trust NYSE Arca Biotechnology Index Fund

iShares Nasdaq Biotechnology ETF

The race to find a coronavirus vaccine is heating up as the latest positive data from progress in trials are being published.

Biotech ETFs to Gain on Coronavirus Vaccine Progress

Biotech exchange-traded funds moved higher Monday as investors tried to sort through winners and losers of the most recent round of COVID-19 treatment results.

Biotech ETFs trade higher on coronavirus treatment news

Global X Robotics & Artificial Intelligence ETF

First Trust NASDAQ Cybersecurity ETF

ProShares Long Online/Short Stores ETF

Global X Cloud Computing ETF

Amplify Cybersecurity ETF

Amplify Online Retail ETF

First Trust Nasdaq Artificial Intelligence & Robotics ETF

First Trust Cloud Computing ETF

In the current scenario, the rising work-from-home and online shopping trend, increasing digital payments, growing video streaming and soaring video game sales are slowly becoming the "new normal."

4 ETF Areas to Keep Soaring as Coronavirus Cases Rise

Moderna

Principal Healthcare Innovators Index ETF

Loncar Cancer Immunotherapy ETF

Amplify Treatments Testing & Advancements ETF

iShares Genomics Immunology and Healthcare ETF

Moderna plans to begin the Phase 3 study of mRNA-1273 this month.

Moderna Inches Closer to Coronavirus Vaccine: ETFs to Shine

Stock futures rocketed higher and are continuing the uptrend in overnight trading on Tuesday after Moderna said its coronavirus vaccine generated antibodies in all patients in an early trial, creating optimism for a swifter economic recovery. Futures on the Dow Jones Industrial Average popped 300 points, while the S&P 500 futures and the Nasdaq 100 [.

Moderna Study Sends Biotech ETFs And Stock Futures Surging

Biotech stocks are breaking out of a seven-year consolidation phase -- and fast. But this rally isn’t slowing down anytime soon.

Biotech Stocks: This Sector Outperformed the Market in Q2

ProShares Ultra Nasdaq Biotechnology

From vaccine-related progress to development of cell therapies for the treatment of coronavirus, all kept the rally in the biotech sector alive.

Top-Performing Biotechnology ETFs Amid Coronavirus Outbreak

SPDR Biotech ETF: Well-Diversified But Volatile And Overbought

Invesco DWA Healthcare Momentum ETF

Biotechnology sector-related exchange traded funds were among the best performers Tuesday as the government program “Operation Warp Speed” allocates billions of dollars for a quick development and delivery of a coronavirus vaccine. On Tuesday, the Invesco DWA Healthcare Momentum Portfolio (NASDAQ: PTH) rose 3.6%, SPDR S&P Biotech ETF (XBI) gained 2.5% and iShares Nasdaq Biotechnology [.

Biotech ETFs Rally as ‘Operation Warp Speed’ Fuels Covid-19 Research

Fidelity MSCI Information Technology Index ETF

iShares U.S. Home Construction ETF

iShares U.S. Technology ETF

Invesco Dynamic Building & Construction ETF

Vanguard Information Technology ETF

SPDR S&P Homebuilders ETF

Technology Select Sector SPDR Fund

Here we highlight three sectors that are sizzling with investing opportunities as the second wave of the outbreak is gathering steam.

3 Hot Sector ETFs to Tide Over the Coronavirus Crisis in Q3

As the coronavirus outbreak continues to aggravate, investors are eyeing developments in vaccine or treatments to combat the pandemic.

Biotech ETFs to Gain as Coronavirus Vaccine Hopes Strengthen

ProShares Short Dow30

ProShares UltraShort Dow30

First Trust Dow Jones Internet Index Fund

SPDR Gold Trust

iShares Gold Trust

Invesco NASDAQ Internet ETF

As the COVID-19 outbreak continues to aggravate in the United States, we discuss some ETF areas that investors can consider for investing in July.

ETF Areas for July as Second Wave of Coronavirus Hits Hard

iShares North American Tech-Software ETF

Invesco QQQ

Invesco Solar ETF

WisdomTree Cloud Computing Fund

SPDR S&P Internet ETF

Given the recent challenges, the S&P 500 and the Dow Jones are in red from a year-to-date look while the Nasdaq has outperformed, gaining nearly 9%.

Top-Ranked ETFs That Crushed the Market in 1H

Bio-Rad Laboratories

Forma Therapeutics Holdings

IMARA

Keros Therapeutics

Vaxcyte

Avidity Biosciences

Repare Therapeutics

Zentalis Pharmaceuticals

Health care companies and governments are racing to find a vaccine or other effective treatment for Covid-19 -- so investors have been piling into stocks like Gilead Sciences, Moderna and Novavax.

Biotech IPOs are booming -- but it's not all about Covid-19

Amplify Mobile Payments ETF

ROBO Global Robotics and Automation ETF

Tortoise Digital Payments Infrastructure Fund

Here we highlight a few ETF areas that have the potential to do well in the second half of this year amid the coronavirus crisis.

Try These ETF Areas in Virus-Impacted Second Half of 2020

iShares U.S. Healthcare ETF

Vanguard Health Care ETF

Health Care Select Sector SPDR Fund

A dashboard with metrics of value, quality and momentum by industries.

Healthcare Dashboard For June

Inovio Pharmaceuticals

Biotechnology sector-related exchange traded funds were among the leaders on Tuesday after the Department of Defense provided funding to Inovio Pharmaceuticals (NasdaqGS: INO) to scale up manufacturing of a DNA vaccine for the novel coronavirus.

Biotech ETFs Rally After Inovio Locks in DOD Coronavirus Deal

Global X Genomics & Biotechnology ETF

Biotechnology sector-related exchange traded funds were among the leaders on Monday after Invitae Corp. (NYSE: NVTA) announced a $1.4 billion deal for ArcherDX, potentially bolstering the genetic information company’s offering lineup and growth outlook.

Biotech ETFs Surge After Invitae Acquires ArcherDX

SPDR S&P Kensho Future Security ETF

SPDR S&P Kensho New Economies Composite ETF

Microsoft

SPDR S&P Kensho Intelligent Structures ETF

SPDR S&P Software & Services ETF

We discuss how investors should position their portfolios for the new normal.

Best ETF Ideas for the Second Half of 2020

Biotech funds are testing their 2015 highs, setting the stage for a major breakout or painful reversal.

Biotech Funds Testing Multi-Year Resistance

Here we take a look at how the latest updates on drugs, antibody therapies and vaccines targeted at winning the coronavirus battle can affect biotech ETFs.

How Are Biotech ETFs Reacting to Coronavirus Treatment News?

iShares Robotics & Artificial Intelligence Multisector ETF

US Global Jets ETF

Here we highlight some ETF areas that will make interesting investment options for investors amid the coronavirus crisis.

These ETF Areas Make Great Investment Choices in June

iShares Silver Trust

SPDR S&P 500 ETF Trust

Visa

Focus On The Most Resilient Equity Sectors - Biotech And Technology

Novavax's latest progress in the Covid-19 vaccine development brings optimism to the Wall Street.

Biotech ETFs Soaring on COVID-19 Vaccine Progress

AstraZeneca

With the race to find a vaccine for the coronavirus, now drugmaker AstraZeneca is the latest to receive funding to generate a panacea.

News for SPDR S&P Biotech ETF ETF (XBI)